文献速递冠心病心力衰竭与心肌病

心脏肌钙蛋白用于评估COVID-19心肌损伤:JACC本周综述

Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week.
PubMed 文献 · J Am Coll Cardiol · 2020-07-08

COVID-19患者中心脏肌钙蛋白升高提示心肌损伤常见,并与心律失常和死亡等不良结局相关。升高更常见于慢性心血管疾病和重症COVID-19患者。SARS-CoV-2感染后的炎症、促血栓和促凝血反应增加急性非缺血性心肌损伤和急性心肌梗死(尤其2型心肌梗死)风险。心肌炎、应激性心肌病、急性心衰和SARS-CoV-2直接损伤是重要病因,但肺栓塞、危重症和脓毒症等非心脏原发情况可能引起更多心肌损伤。结构化使用连续心脏肌钙蛋白有助于风险分层、决定影像学检查时机、指导分期分类和疾病表型分析。

要点

  • COVID-19患者心脏肌钙蛋白升高提示心肌损伤,与心律失常和死亡等不良结局相关。
  • 慢性心血管疾病和重症COVID-19患者更易出现肌钙蛋白升高。
  • 连续检测心脏肌钙蛋白有助于风险分层和影像学决策。

核心结论

  • COVID-19患者心脏肌钙蛋白升高提示心肌损伤,与不良结局相关,连续检测有助于风险分层和临床决策。

研究设计与样本

  • 本文为JACC综述,总结COVID-19心肌损伤的机制、病因及心脏肌钙蛋白的应用价值。

主要发现

  • 心脏肌钙蛋白升高在COVID-19患者中常见,与心律失常和死亡等不良结局相关。
  • 升高更常见于慢性心血管疾病患者和重症COVID-19患者。
  • SARS-CoV-2感染后的炎症、促血栓和促凝血反应增加急性非缺血性心肌损伤和急性心肌梗死风险,尤其2型心肌梗死。
  • 心肌炎、应激性心肌病、急性心衰和SARS-CoV-2直接损伤是重要病因,但肺栓塞、危重症和脓毒症等非心脏原发情况可能引起更多心肌损伤。

关键数值与推荐

  • 连续检测心脏肌钙蛋白可用于风险分层、决定影像学检查时机、指导分期分类和疾病表型分析。

临床怎么用

  • 对住院COVID-19患者结构化使用连续心脏肌钙蛋白检测,以辅助风险分层和影像学决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Increases in cardiac troponin indicative of myocardial injury are common in patients with coronavirus disease-2019 (COVID-19) and are associated with adverse outcomes such as arrhythmias and death. These increases are more likely to occur in those with chronic cardiovascular conditions and in those with severe COVID-19 presentations. The increased inflammatory, prothrombotic, and procoagulant responses following severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection increase the risk for acute nonischemic myocardial injury and acute myocardial infarction, particularly type 2 myocardial infarction, because of respiratory failure with hypoxia and hemodynamic instability in critically ill patients. Myocarditis, stress cardiomyopathy, acute heart failure, and direct injury from SARS-CoV-2 are important etiologies, but primary noncardiac conditions, such as pulmonary embolism, critical illness, and sepsis, probably cause more of the myocardial injury. The structured use of serial cardiac troponin has the potential to facilitate risk stratification, help make decisions about when to use imaging, and inform stage categorization and disease phenotyping among hospitalized COVID-19 patients.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Sandoval Y, Januzzi JL, Jaffe AS, et al. Cardiac Troponin for Assessment of Myocardial Injury in COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol. 2020. PMID: 32652195. doi:10.1016/j.jacc.2020.06.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。